Gisela Maame Abbam | |
---|---|
Born | |
Education | Wesley Girls' Senior High School University of Cape Coast Middlesex University |
Occupation | Business executive |
Known for | First black Chair of the General Pharmaceutical Council and British Science Association |
Gisela Maame Abbam FRSA is a Ghanaian-British businesswoman working in both the private and public sector who has focused on the healthcare industry. She is the first black Chair of the General Pharmaceutical Council, [1] and is the first black chair of the British Science Association. [2] She is a board member of the Bar Standards Board, [3] a commissioner on the National Preparedness Commission [4] as well as a Senior director at Revvity. She is a former Global Executive Director at General Electric and an advisor at National Institute for Health and Care Excellence.
Gisela has had an extensive career in both the public and private sectors including NICE (the National Institute for Health and Care Excellence), and General Electric (otherwise known as GE) where she set up a global function that within a year was generating $600 million with a pipeline of $3 billion; as well as Abt Associates [5] and PerkinElmer. From the UN [ citation needed ] to the World Bank and all the way to the WTO, Gisela has worked with, advised and negotiated with many multilateral organisations, as well as governments such as Turkey, France, and the US. More recently she hosted the high-level Ukrainian delegation who came to the UK to start the process of rebuilding their security and health systems. Gisela was presented with a Ukrainian medal at this meeting.[ citation needed ]
Abbam was born in Ghana to H.E Peter Abbam, a high ranking Diplomat and Ambassador and Eileen Abbam (née Dove), a former headmistress at Ridge Church School and a daughter of Frans Dove, a Sierra Leonean Barrister and notable member of the West African Aristocratic Dove Family. [6] She attended Wesley Girls' Senior High School and later She earned a Bachelor’s degree in Education with honours from University of Cape Coast; and an MBA from Middlesex University.
Abbam is a Senior Global Executive and the Chair of the General Pharmaceutical Council, [7] UK. She was also the Chair of the British Science Association. [8] Other boards she serves on include the Bar Standards Board [9] Everywoman [10] and the Briyah Institute. She is a committee member for the Longitude Prize. [11]
She has worked in collaboration with governments, the World Health Organization (WHO), [12] the UN, World Bank and others to improve health outcomes. Additionally, she is a subject matter expert in global health solutions, [13] has written more than 50 white papers on various public policy issues, and is a sought-after speaker for International conferences. [14]
Abbam worked at the National Institute for Health and Care Excellence early on in her career. [15]
She joined General Electric Healthcare [16] in 2007 where she was the first Head of Government Affairs & Policy for UK & Ireland. She subsequently became the inaugural Global Executive Director for Government Affairs and Policy for General Electric Healthcare and set up the Division globally. She was responsible for the strategic direction of government affairs and policy for GE Healthcare, [17] [18] the then $18 billion business unit of GE that provides transformational medical technologies to health customers in over 100 countries. [19] Gisela drove business growth and initiated over £1 billion new business opportunities over a 5-year period.
In 2009, she initiated and led an early diagnosis campaign in UK with a number of NGO's. This was aimed at aimed at Members of Parliament and resulted in access to direct referral for diagnostics by General Practitioners amongst others as well as gaining the support of then Prime Minister, David Cameron.
She was the founding Chair of the Global Diagnostic Imaging, Healthcare IT & Radiation Therapy Trade Association (DITTA) [20] Global Health Working Group which represents over 600 companies and is focused on working with WHO [21] and the World Bank.
In 2016, she was one of 14 people selected to serve as a Committee Member for the Global Health and the Future Role of the United States – a report for the incoming Trump Administration by the US National Academies of Science, Engineering and Medicines [22]
She was a key part of the team that successfully negotiated trade policy at WTO on the elimination of tariffs on key medical devices to enable increased access for patients in 80 countries.
She was the Director of Strategic Partnerships and Company Officer for Abt Associates, [23] one of the top 20 global research firms and top 40 International development innovators.
She has been the inaugural Executive in her last 4 roles and is successful at creating new functions and making them commercially viable. She also guest lectures at University College London. [24] She has also guest lectured at Leeds Business School [25]
The healthcare industry is an aggregation and integration of sectors within the economic system that provides goods and services to treat patients with curative, preventive, rehabilitative, and palliative care. It encompasses the creation and commercialization of products and services conducive to the preservation and restoration of well-being. The contemporary healthcare sector comprises three fundamental facets, namely services, products, and finance. It can be further subdivided into numerous sectors and categories and relies on interdisciplinary teams of highly skilled professionals and paraprofessionals to address the healthcare requirements of both individuals and communities.
GE HealthCare Technologies, Inc. is an American multinational medical technology company headquartered in Chicago, Illinois. It was spun-off from General Electric on January 4, 2023, with GE retaining 6.7%. As of 2017, it is a manufacturer and distributor of diagnostic imaging agents and radiopharmaceuticals for imaging modalities used in medical imaging procedures. It offers dyes used in magnetic-resonance-imaging procedures; manufactures medical diagnostic equipment, including CT image machines; MRI, X-ray; ultrasound; cath labs; mammogram; Nuclear Medicine Cameras; and develops health technology for medical imaging and information technologies, medical diagnostics, patient monitoring systems, disease research, drug discovery, and biopharmaceutical manufacturing. It was incorporated in 1994 and operates in more than 100 countries.
Amersham plc was a manufacturer of radiopharmaceutical products, to be used in diagnostic and therapeutic nuclear medicine procedures. The company became GE Healthcare following a takeover in 2003, which was based at the original site in Amersham, Buckinghamshire until 2016, when the headquarters moved to Chicago.
Regulatory affairs (RA), is a profession that deals with an organization’s adherence to regulatory compliance.
George Henry Poste, CBE FRS, is a former director of the Biodesign Institute at Arizona State University.
The International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) is a trade association that represents internationally over 90 pharmaceutical companies and associations around the world. IFPMA is based in Geneva and is in official relations with the United Nations where it contributes industry expertise to global health discussions.
The Health and Social Care Select Committee is a Departmental Select Committee of the British House of Commons, the lower house of the United Kingdom Parliament. Its remit is to examine the policy, administration and expenditure of the Department of Health and Social Care (DHSC) and its associated agencies and public bodies. The Clerks of the Committee are Previn Desai and Joanna Dodd.
The P. D. Hinduja National Hospital and Medical Research Centre is a multi-specialty, tertiary-care hospital in Mumbai, India. It was founded in 1951 by Parmanand Deepchand Hinduja, in collaboration with the Massachusetts General Hospital, the main teaching hospital of Harvard Medical School, Boston.
Global Medical Device Nomenclature (GMDN) is a system of internationally agreed generic descriptors used to identify all medical device products. This nomenclature is a naming system for products which include those used for the diagnosis, prevention, monitoring, treatment or alleviation of disease or injury in humans.
The Ministry of Health is a ministry of the Government of Malaysia that is responsible for health system: health behaviour, cancer, public health, health management, medical research, health systems research, respiratory medicine, health promotion, healthcare tourism, medical device, blood collection, leprosy control, clinical research, health care, dental care, health institution, laboratory, pharmaceutical, patient safety.
Kavita Oberoi is a British entrepreneur. She founded Oberoi Consulting, an IT and Business Healthcare Consultancy in 2001.
Dr Purshotam Lal is an Indian Interventional cardiologist who has to his credit the pioneering of over 20 interventional cardiology procedures for the first time in India, some of which were the first time in the World. Trained in UK, US and Germany, and he has held various faculty positions including Professor, Advisor, etc.
Ilona Kickbusch is a German political scientist best known for her contribution to health promotion and global health. She is adjunct professor at the Graduate Institute of International and Development Studies, Geneva.
Jeremy Levin is a South African-born biopharmaceutical executive and medical doctor. In 2018, Levin was named as one of the most influential figures in the biopharmaceutical industry and, in 2023, was awarded the Lifetime Achievement Award at the 19th Annual Scrip Awards in London.
Prof. Richard Barker is a healthcare leader who has contributed to the field through his forward-thinking approach and innovative work. He co-founded and chairs Metadvice, a company developing AI-driven healthcare platforms. He also established New Medicine Partners and is the Founding Director of the University of Oxford's Centre for the Advancement of Sustainable Medical Innovation, now called the Collaboration for the Advancement of Sustainable Medical Innovation (CASMI), which is hosted by University College London and focuses on translating bioscience into medical treatments. Barker is the chair of the advisory board at NWPharmaTech and a co-founder and board member of 2BWell, a mental health initiative supporting Ukrainians. Additionally, he is a visiting professor in Precision Population Health at King’s College London.
Jeroen Tas is a Dutch entrepreneur and senior executive in the healthcare, information technology and financial services industries. In February 2017, he assumed the role as Chief Innovation & Strategy Officer at Philips Healthcare, a position he held until July 2021. He currently works on Strategic Business Development and is also a member of the executive committee at Royal Philips.
Diane Kingston, is a human rights defender and international development specialist. She is the Global Technical Lead for Disability Rights and Equalities Sightsavers and a volunteer for Shout- the mental health crisis text service
Patrick Joseph McGuinness is a former senior British civil servant who now advises businesses and governments globally on their resilience, crisis, technology, data and cyber issues.
Michael J. Barber is an American engineer who is an executive at General Electric. His research considers X-ray electronics. He was elected Fellow of the American Institute for Medical and Biological Engineering in 2014.
Nisa Leung is a venture capitalist and managing partner at Qiming Venture Partners. She has been named on the Forbes Midas List for six consecutive years since 2019. and ranked top 2 in Best Women Venture Capitalists by Forbes China for three successive years since 2021. She was awarded The Fortune Most Powerful Women Asia in 2024 by Fortune Asia and The Most Powerful Women in Business by Fortune China from 2022 to 2024. Nisa is widely known as China's leading investor in healthcare.
This article needs additional or more specific categories .(November 2023) |